EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessment of Mortality Risk in Patients With Community‐Acquired Pneumonia: Role of Novel Inflammatory Biomarkers

Burcu Baran iD, Nur Aleyna Yetkin iD, Bilal Rabahoğlu iD, Nuri Tutar iD, İnci Gülmez iD

Journal of Clinical Laboratory Analysis · 2025-09 · 39 (17)

DOI: 10.1002/jcla.70081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 13.08.2025. Verfasst von Burcu Baran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, Erciyes University Medical School, Kayseri, Turkey. Hauptthemen laut MEDLINE: Community-Acquired Infections, Biomarkers, Pneumonia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pneumonia is a lung parenchyma infection with clinical presentations ranging from mild to life‐threatening. Its severity depends on factors such as the causative pathogen, the host's immune response, and existing comorbidities. This study aimed to investigate the prognostic value of novel inflammatory biomarkers for predicting in‐hospital mortality in patients with community‐acquired pneumonia (CAP).

Methods

This retrospective cross‐sectional study included 207 hospitalized patients diagnosed with clinically and radiologically confirmed pneumonia. Laboratory data collected upon admission included complete blood count parameters, C‐reactive protein (CRP), creatinine, and albumin levels. Systemic inflammatory biomarkers such as the neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), CRP‐to‐albumin ratio (CAR), CRP‐to‐lymphocyte ratio (CLR), systemic immune‐inflammation index (SII), systemic inflammatory response index (SIRI), prognostic nutritional index (PNI), and C‐reactive protein‐albumin‐lymphocyte (CALLY) index were calculated.

Results

The cohort was predominantly male (69%, n = 142) with a mean age of 62.1 ± 16.3 years. The median hospital stay was 8 days, with an 11% mortality rate. Malignancy was more frequent in the nonsurvivor group ( p = 0.001). Nonsurvivors had significantly lower hemoglobin ( p < 0.001) and albumin ( p = 0.004) levels, while CRP ( p = 0.024) and creatinine ( p = 0.002) were elevated. NLR ( p = 0.009), CAR ( p = 0.011), CLR ( p = 0.006), SII ( p = 0.013), and SIRI ( p = 0.024) were higher in nonsurvivors, while PNI ( p = 0.010) and CALLY ( p = 0.003) were lower.

Conclusion

Novel inflammatory biomarkers, particularly the CALLY index, are valuable for mortality prediction in CAP, aiding in risk stratification and early management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsBiomarkersPneumoniaHumansMaleFemaleMiddle AgedRetrospective StudiesAgedCross-Sectional StudiesC-Reactive ProteinInflammationHospital MortalityPrognosisCommunity-Acquired Pneumonia

Stichwörter der Autor:innen

C‐reactive proteinbiomarkerscommunity‐acquired infectionsinflammationlymphocytesmortalitypneumoniaserum albumin

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Respiratory Diseases, Erciyes University Medical School, Kayseri, Turkey.

ORCID-Profile: Burcu Baran, Nur Aleyna Yetkin, Bilal Rabahoğlu, Nuri Tutar, İnci Gülmez

Zitieren

APA

Baran, B., Yetkin, N. A., Rabahoğlu, B., Tutar, N., & Gülmez, İ. (2025). Assessment of Mortality Risk in Patients With Community‐Acquired Pneumonia: Role of Novel Inflammatory Biomarkers. Journal of Clinical Laboratory Analysis, 39(17). https://doi.org/10.1002/jcla.70081

Vancouver

Baran B, Yetkin NA, Rabahoğlu B, Tutar N, Gülmez İ. Assessment of Mortality Risk in Patients With Community‐Acquired Pneumonia: Role of Novel Inflammatory Biomarkers. Journal of Clinical Laboratory Analysis. 2025;39(17). doi:10.1002/jcla.70081

BibTeX
@article{Baran2025,
  author = {Baran, Burcu and Yetkin, Nur Aleyna and Rabahoğlu, Bilal and Tutar, Nuri and Gülmez, İnci},
  title = {Assessment of Mortality Risk in Patients With Community‐Acquired Pneumonia: Role of Novel Inflammatory Biomarkers},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2025},
  volume = {39},
  number = {17},
  doi = {10.1002/jcla.70081}
}
Kostenlos starten →